Details of the Drug
General Information of Drug (ID: DMLJDU5)
| Drug Name |
4-nitro-N-(quinolin-8-yl)benzenesulfonamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL540966; 33757-62-9; AC1NAKSM; SCHEMBL13485922; CTK1B1556; DTXSID90403445; MolPort-007-041-512; ZINC5681580; BDBM50372514; AKOS024374275; MCULE-8526334160; NCGC00161718-01; 4-nitro-N-quinolin-8-ylbenzenesulfonamide; N-(8-Quinolyl)-4-nitrobenzenesulfonamide; 4-nitro-N-(8-quinolyl)benzenesulfonamide; [(4-nitrophenyl)sulfonyl]-8-quinolylamine; ST51013795; Benzenesulfonamide, 4-nitro-N-8-quinolinyl-; 4-nitro-N-(quinolin-8-yl)benzene-1-sulfonamide; CU-00000000141-1
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 329.3 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 6 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


